Stocks / BDX

BDX stock

BECTON DICKINSON & CO · Healthcare · Medical Instruments & Supplies

The model's rating

The model does not currently score BDX.

Compare BDX with RMD

Where this rating comes from: The Upfront Model, whose picks have been recorded with a fingerprint the day they publish since September 18, 2026. See the record.

BDX is not among the 20 largest holdings published for 2026 Q4. See the portfolio

BDX against the S&P 500

PeriodBDXS&P 500 (SPY)
1 month+13.3%-4.7%
3 months+15.9%-4.8%
Year to date+42.8%+7.9%
1 year+44.9%+11.8%

Total return, dividends included.

Key numbers

Price$216.08
Market cap58.86 Billion
P/E (trailing 12 months)65.1
P/S (trailing 12 months)2.8
P/B (latest quarter)2.0
Gross margin46.4%
Net profit margin4.5%
Return on equity3.8%
Beta0.3

As of August 6, 2026.

BDX and its closest peers

StockCompanyMarket capModel rating
RMD RESMED INC 34.12 Billion Outperform BDX vs RMD
WST WEST PHARMACEUTICAL SERVICES INC 28.14 Billion Greatly Underperform BDX vs WST
BAX BAXTER INTERNATIONAL INC 13.53 Billion Greatly Outperform BDX vs BAX
COO COOPER COMPANIES INC 11.55 Billion Underperform
ISRG INTUITIVE SURGICAL INC 145.92 Billion Outperform ISRG vs BDX

Questions

How is the BDX rating produced?

A machine-learning model forecasts each stock's return over the coming months and ranks the forecasts against each other. The label says where this stock's forecast falls in that ranking. It is refreshed whenever the model's data updates, normally every trading day.

Is BDX in the Upfront Investment model portfolio?

BDX is not among the 20 largest holdings published for 2026 Q4.

The rating is generated by The Upfront Model and can be wrong. It is not investment advice and takes no account of your circumstances. Past performance does not guarantee future results.